Medical Properties Trust, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MPT research report →
Range $2 – $3.8
Price Chart
About the company
Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements.
- CEO
- Edward K. Aldag Jr.
- IPO
- 2005
- Employees
- 121
- HQ
- Birmingham, AL, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a deep downtrend, trading far below its 200-day average of 4.48 and 50-day average of 3.20. It is sitting near the 52-week low of 1.80, which keeps the chart in a damaged, late-cycle recovery regime rather than a confirmed reversal.
Street sentiment is cautious: consensus is Hold, with 11 Buys, 12 Holds, and 5 Sells. The average target sits at 2.90, above the last close but far below prior levels, and RBC’s recent downgrade to Underperform reinforces a defensive stance.
The recent earnings pattern is mixed, with 2 beats in the last 8 quarters and two straight misses in the latest reports. Next-year EPS estimates are still negative at -0.025, so shareholders should watch whether rent collections, asset sales, and financing costs can stabilize results.
The pattern leans constructive, but most of the activity is automatic in-kind compensation rather than discretionary trading. The only clear open-market buy was a 2,300-share purchase by the Senior VP, Controller & CAO, while the larger filings from senior leadership look like routine award or withholding-related flows.
Profitability is solid on paper, with a 95.7% gross margin, 56.9% operating margin, and 22.9% net margin. Revenue still declined 5.4% year over year, and the balance sheet remains heavily levered with $9.83 billion of debt against $540.9 million of cash.
MPT screens as a high-yield, distressed healthcare REIT rather than a clean-growth peer. The valuation is still depressed versus the sector, with a 4.37 P/E and a market price well below the 200-day trend, reflecting elevated balance-sheet risk.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.06B
- P/E
- 4.36
- Fwd P/E
- 16.06
- PEG
- 0.00
- P/S
- 1.05
- P/B
- 0.24
- EV/EBITDA
- 7.21
- Div Yield
- 19.78%
- Gross Margin
- 82.46%
- Op Margin
- 55.11%
- Net Margin
- 24.14%
- ROE
- 5.45%
- ROIC
- 4.07%
Latest fiscal year · YoY change
- Revenue
- $972.02M-2.4%
- Gross Profit
- $935.61M-3.4%
- Op Income
- $539.77M
- Net Income
- $-277,049,000+88.5%
- EPS
- $-0.46+88.6%
- OCF Growth
- -6.0%
- FCF Growth
- -6.0%
- 52W High
- $6.47
- 52W Low
- $1.72
- 50D MA
- $3.07
- 200D MA
- $4.43
- Beta
- 1.55
- RSI (14)
- 15
- Avg Volume
- 14.15M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Medical Properties Trust said Q3 results were in line with expectations, while asset sales and refinancing activity strengthened the balance sheet and management remained upbeat on portfolio operating trends despite HSA and Priory headwinds.· October 29, 2026
- Normalized FFO was $0.11 per share, and management said results were in line with expectations except for the nonpayment of September rent from HSA.
- MPT said year-to-date cash revenue topped $750 million, supporting confidence in reaching more than $1 billion of annualized cash rental revenue and still above $1 billion in 2027 even after asset sales.
- The company completed a $2.4 billion secured refinancing, recorded a $123 million net discount, recognized $70 million of that as gain in the quarter, and said step 2 should eliminate 2027 maturities once completed.
- Priory agreed to an approximately GBP 11 million annual rent reduction in exchange for a variable rent recapture mechanism and a lease extension option to 2055.
- HSA’s operations were described as stronger, with surgeries up 33%, overall volume up 14% since September, and cash collections up 24% since August after Ovation began reviewing operations.
MPT reported normalized FFO of $0.11 per share for Q3 2026, in line with expectations except for the nonpayment of September rent from HSA. The company said it completed a $2.4 billion secured debt refinancing in August, capturing an approximate $123 million net discount, with $70 million recognized as a gain in the quarter. It also recorded $158 million of gains on asset sales and about $24 million of impairment charges, primarily tied to Colombia after the August earthquake. G&A was lower year over year, mainly due to stock compensation expense changes. For guidance, management said year-to-date cash revenue already exceeds $750 million, annualizing to more than the previously stated $1 billion target, and it continues to expect portfolio cash rents above $1 billion in 2027. On debt, management expects step 2 of the refinancing to remove 2027 maturities, with no maturities until June 2028 once completed, not counting cash on hand as of September 30.
Ed Aldag framed the quarter around portfolio resilience, balance-sheet progress, and operational fixes at challenged operators. He emphasized that MPT already collected more than $750 million of cash revenue year to date, despite having sold 9 properties for about $600 million of proceeds, and said the company still expects more than $1 billion of portfolio cash rents in 2027. On HSA, he said the issue is billing and collections rather than hospital operations, and expressed confidence that Ovation Healthcare can improve performance. On Priory, he described the rent reset as a response to NHS budget pressure and said the company is confident in the operator’s longer-term prospects.
Steve Hamner focused on liquidity, maturities, and covenant flexibility. He outlined the completed $2.4 billion secured notes issuance in August and step 2 of the refinancing plan, which includes extending the revolver, repaying the $200 million term loan due in June 2027, and refinancing the remaining $665 million of 2027 notes. He said the new revolver is expected to eliminate the secured leverage covenant and add headroom under the fixed charge coverage and total leverage covenants, while the company plans to downsize the current roughly $1.3 billion revolver and free collateral for further secured financing. He also said the company’s unencumbered assets to unsecured debt ratio was more than 180% as of September 30 and could rise to 225% after step 2, with additional flexibility from asset-sale proceeds and cash on hand.
Analysts pressed on HSA rent timing and whether MPT would move to a more drastic plan if operations worsen. Management said it has not projected when rent will resume, but said HSA’s operations remain strong, surgeries and volumes are rising, and Ovation is focused on fixing billing and collections; Aldag said a more drastic move would only be considered if operations decline. Questions also focused on Priory’s rent cut and what MPT received in return; management said it gained a much improved credit perimeter and the ability to extend the lease to 2055, while rent can recover as revenue improves. On capital allocation, management said there are no meaningful asset sales pending and that it has time and flexibility before considering more drastic alternatives.
The company pointed to multiple signs that its diversified portfolio is holding up well, including strong performance in Europe, stable general acute trends, and improving post-acute momentum. Management also highlighted a successful refinancing, substantial asset-sale gains, and the prospect of no maturities until June 2028 once step 2 is finished, which they said should give MPT more flexibility to keep deleveraging.
Two key problem areas remain HSA and Priory. HSA did not pay September rent, and management could not say when rent collections will resume, while Priory’s rent was reduced by about 18% because of NHS budget pressure. The company also recorded $24 million of impairment charges tied mainly to Colombia after the earthquake, underscoring that operating and geopolitical setbacks can still affect results.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 82.1%
- Shares Outstanding
- 597.16M
- Float Shares
- 490.04M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Held by 303 ETFs
Biggest fund positions in MPT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 7, 26 | Aldag Edward K JR | other | 109,433 |
| Oct 7, 26 | HAMNER R STEVEN | other | 48,548 |
| Oct 7, 26 | Portal Larry H | other | 4,048 |
| Oct 7, 26 | Hanna James Kevin | other | 3,295 |
| Oct 7, 26 | Williams Rosa Handley | other | 1,938 |
| Oct 7, 26 | LAMBERT CHARLES R | other | 2,347 |
| Aug 20, 26 | Hanna James Kevin | buy | 2,300 |
| Jul 8, 26 | Portal Larry H | other | 4,048 |
| Jul 8, 26 | LAMBERT CHARLES R | other | 2,347 |
| Jul 8, 26 | Aldag Edward K JR | other | 109,433 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MPT coverage
Recent articles, reports, and earnings notes.

Medical Properties Trust (MPW): Balance-Sheet Repair Story
Medical Properties Trust is a high-risk REIT recovery story built on hospital rent collections, asset sales, and refinancing progress. The stock offers upside if tenant performance improves, but leverage and weak earnings estimates keep the risk profile elevated.

Medical Properties Trust, Inc. (MPT) falls on deep earnings
Medical Properties Trust, Inc. (MPT) beat EPS and revenue, yet shares fell as investors looked past the headline to debt, rent collection, and tenant recovery. This deep-dive examines coverage ratios, refinancing progress, normalized FFO, and the path to more durable cash flow.

Medical Properties Trust (MPW): Rent Recovery vs. Leverage Risk
Medical Properties Trust shows a credible stabilization story as rent ramps and restructurings improve, but heavy leverage and tenant risk keep the stock in Hold territory.
Want a deeper read on MPT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Medical Properties Trust: I Was Wrong, The Market Is Not (Rating Downgrade)
seekingalpha.com · Nov 11
Lowey Dannenberg, P.C. is Investigating Medical Properties Trust, Inc. (NYSE: MPT) for Potential Violations of the Federal Securities Laws
globenewswire.com · Nov 9
Lost Money on Medical Properties Trust, Inc. Shares? The Law Offices of Frank R. Cruz Continues Investigating Potential Securities Fraud After 11.3% Stock Decline
globenewswire.com · Nov 9
Lost Money on Medical Properties Trust, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Continues Investigating Possible Securities Fraud After 11.3% Share Price Drop
globenewswire.com · Nov 9
Are Your Dividends Safe? 4 Companies Whose Debt Is Competing With the Payout
247wallst.com · Nov 5
698,949 Shares in Medical Properties Trust, Inc. $MPT Bought by Asset Management One Co. Ltd.
defenseworld.net · Nov 3
Medical Properties Trust Q3 Earnings Call Highlights
marketbeat.com · Oct 30
Medical Properties Trust's Collapse Offers A Golden Buying Opportunity
seekingalpha.com · Oct 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 9, 2026 · Live quote · Not investment advice